Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Studies from Osaka University have provided new information about life sciences
December 24th, 2008
According to recent research from Suita, Japan, "Control of African trypanosomiasis caused by the protozoan parasite Tryponosoma brucei is an important issue in medicine, veterinary medicine, and agricultural economy." "Because vaccine development is unlikely, development of safer and more effective chemotherapeutics is critical. The biosynthetic pathway of glycosylphosphatidylinositol (GPI), which acts as membrane anchors of coat proteins, variant surface glycoproteins, and transferrin receptors, is a validated target of drug development," wrote T. Kinoshita and colleagues, Osaka University. The researchers concluded: "An article in this issue...
Source: Vaccine Weekly (2008-12-24)
|
